Lactobacillus kefiranofaciens M1 isolated from milk kefir grains ameliorates experimental colitis in vitro and in vivo
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Lactobacillus kefiranofaciens M1, isolated from and identified in Taiwanese milk kefir grain, has demonstrated immune-modulating activity. In the present study, we further investigated the effects of Lb. kefiranofaciens M1 on intestinal epithelial cells in vitro and on dextran sodium sulfate (DSS)-induced colitis in vivo. The possible mechanisms regarding the cytokine products and intestinal epithelial barrier restoration as well as the putative receptor for the protective effects of Lb. kefiranofaciens M1 were investigated. In vitro results indicated that Lb. kefiranofaciens M1 could strengthen the epithelial barrier function in vitro by increasing the transepithelial electrical resistance (TEER) and significantly upregulated the level of the chemokine CCL-20 at both the apical and basolateral sites. The in vivo effects of Lb. kefiranofaciens M1 on the regulation of intestinal physiology indicate that this strain could ameliorate DSS-induced colitis with a significant attenuation of the bleeding score and colon length shortening. Production of proinflammatory cytokines was decreased and that of the antiinflammatory cytokine IL-10 was increased in the DSS-treated mice given Lb. kefiranofaciens M1. The putative receptor for the protective effects of Lb. kefiranofaciens M1 was toll-like receptor 2 (TLR2), which was involved in probiotic-induced cytokine production in vitro and in attenuation of the bleeding score and colon length shortening in vivo. In this study, the kefir lactobacillus Lb. kefiranofaciens M1 clearly demonstrated an anticolitis effect. Based on these results, Lb. kefiranofaciens M1 has the potential to be applied in fermented dairy products as an alternative therapy for intestinal disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chemically induced mouse models of intestinal inflammation
Wirtz, S., Neufert, C., Weigmann, B., & Neurath, M. F. (2007) · Nature Protocols · doi:10.1038/nprot.2007.41 · Cited by 1,567
Probiotics and the gut microbiota in intestinal health and disease
Gareau, M. G., Sherman, P. M., & Walker, W. A. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.117 · Cited by 907
Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function
Cario, E., Gerken, G., & Podolsky, D. K. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.056 · Cited by 697
Karczewski, J., Troost, F. J., Konings, I., Dekker, J., Kleerebezem, M., Brummer, R.-J. M., & Wells, J. M. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00327.2009 · Cited by 676 · cited 5×
“…Lb. acidophilus (Resta-Lenert and Barrett, 2003, 2006), Escherichia coli Nissle 1917 (Zyrek et al., 2007), and Lb. plantarum (Anderson et al., 2010; Karczewski et al., 2010) have also been reported to enhance TEER and resist proinflammatory cytokine- or pathogen-induced barrier dysfunction in…”
BackgroundMethodInfluentialResta-Lenert, S., & Barrett, K. E. (2003) · Gut · doi:10.1136/gut.52.7.988 · Cited by 642
Mechanisms of action of probiotics: Recent advances
Ng, S. C., Hart, A. L., Kamm, M. A., Stagg, A. J., & Knight, S. C. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20602 · Cited by 596 · cited 1×
“However, few studies have investigated the possible role of TLR2 in the underlying mechanisms of the protective effects of probiotics on colitis (Vanderpool et al., 2008; Ng et al., 2009).”
BackgroundProbiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity
Ukena, S. N., Singh, A., Dringenberg, U., Engelhardt, R., Seidler, U., Hansen, W., Bleich, A., Bruder, D., Franzke, A., Rogler, G., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001308 · Cited by 482 · cited 1×
“Probiotics are also capable of upregulating expression of defensins (Schlee et al., 2008), mucins (CaballeroFranco et al., 2007), and proteins related to tight junctions (Ukena et al., 2007).”
BackgroundAntimutagenic and antioxidant properties of milk-kefir and soymilk-kefir
Liu, J.-R., Chen, M.-J., & Lin, C.-W. (2005) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf048934k · Cited by 217
Self-citationKlingberg, T. D., Pedersen, M. H., Cencic, A., & Budde, B. B. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.11.7528-7530.2005 · Cited by 118
Hypocholesterolaemic effects of milk-kefir and soyamilk-kefir in cholesterol-fed hamsters
Liu, J.-R., Wang, S.-Y., Chen, M.-J., Chen, H.-L., Yueh, P.-Y., & Lin, C.-W. (2006) · British Journal of Nutrition · doi:10.1079/bjn20061752 · Cited by 115 · cited 2×
“, 2005), and hypocholesterolemic effects (Liu et al., 2006).”
BackgroundSelf-citationAntitumor Activity of Milk Kefir and Soy Milk Kefir in Tumor-Bearing Mice
Liu, J.-R., Wang, S.-Y., Lin, Y.-Y., & Lin, C.-W. (2002) · Nutrition and Cancer · doi:10.1207/s15327914nc4402_10 · Cited by 114
Voltan, S., Castagliuolo, I., Elli, M., Longo, S., Brun, P., D'Incà, R., Porzionato, A., Macchi, V., Palù, G., Sturniolo, G. C., et al. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00079-07 · Cited by 96 · cited 2×
“…in mice, including antiinflammatory effects (Mileti et al., 2009), regulation of intestinal barrier function, increase in barrier regulating proteins (Miyauchi et al., 2009), and activation of peroxisome proliferator-activated receptor gamma (Castagliuolo et al., 2005; Voltan et al., 2007, 2008).”
Background
Research works printed but not linked: 44
- Agle, 2010, Calcium mobilization triggered by the chemokine CXCL12 regulates migration in wounded intestinal epithelial monolayers, J. Biol. Chem., 285, 16066, 10.1074/jbc.M109.061416 · DOI
- Anderson, 2010, Lactobacillus plantarum DSM 2648 is a potential probiotic that enhances intestinal barrier function, FEMS Microbiol. Lett., 309, 184
- Araki, 2006, In vitro effects of dextran sulfate sodium on a Caco-2 cell line and plausible mechanisms for dextran sulfate sodium-induced colitis, Oncol. Rep., 16, 1357
- Caballero-Franco, 2007, The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells, Am. J. Physiol. Gastrointest. Liver Physiol., 292, G315, 10.1152/ajpgi.00265.2006 · DOI · Paper page
- Cai, 2010, Live and lyophilized Lactobacillus species elicit differential immunomodulatory effects on immune cells, FEMS Microbiol. Lett., 302, 189, 10.1111/j.1574-6968.2009.01853.x · DOI
- Cario, 2004, Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C, Gastroenterology, 127, 224, 10.1053/j.gastro.2004.04.015 · DOI · Paper page
- Castagliuolo, 2005, Beneficial effect of auto-aggregating Lactobacillus crispatus on experimentally induced colitis in mice, FEMS Immunol. Med. Microbiol., 43, 197, 10.1016/j.femsim.2004.08.011 · DOI · Paper page
- Chen, 2008, Microbiological study of lactic acid bacteria in kefir grains by culture-dependent and culture-independent methods, Food Microbiol., 25, 492, 10.1016/j.fm.2008.01.003 · DOI · Paper page
- Chen, 2009, Therapeutic effects of four strains of probiotics on experimental colitis in mice, World J. Gastroenterol., 15, 321, 10.3748/wjg.15.321 · DOI · Paper page
- Fajdiga, 2006, Interference of Salmonella enteritidis and Lactobacillus spp. with IL-8 levels and transepithelial electrical resistance of enterocyte-like Caco-2 cells, Folia Microbiol. (Praha), 51, 268, 10.1007/BF02931810 · DOI
- Fitzpatrick, 2008, In vitro and in vivo effects of the probiotic Escherichia coli strain M-17: Immunomodulation and attenuation of murine colitis, Br. J. Nutr., 100, 530, 10.1017/S0007114508930373 · DOI
- Geier, 2007, Inflammatory bowel disease: Current insights into pathogenesis and new therapeutic options: Probiotics, prebiotics and synbiotics, Int. J. Food Microbiol., 115, 1, 10.1016/j.ijfoodmicro.2006.10.006 · DOI · Paper page
- Gibson, 2008, Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis, Cell. Microbiol., 10, 388
- Herías, 2005, Probiotic effects of Lactobacillus casei on DSS-induced ulcerative colitis in mice, Int. J. Food Microbiol., 103, 143, 10.1016/j.ijfoodmicro.2004.11.032 · DOI
- Hoarau, 2008, Supernatant from Bifidobacterium differentially modulates transduction signaling pathways for biological functions of human dendritic cells, PLoS ONE, 3, e2753, 10.1371/journal.pone.0002753 · DOI · Paper page
- Hong, 2009, Effects of kefir supernant and lactic acid bacteria isolated from kefir grain on cytokine production by macrophage, Int. Dairy J., 19, 244, 10.1016/j.idairyj.2008.10.010 · DOI
- Johnson-Henry, 2008, Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function, Infect. Immun., 76, 1340, 10.1128/IAI.00778-07 · DOI · Paper page
- Kaji, 2010, Bacterial teichoic acids reserve predominant IL-12 production induced by certain Lactobacillus strains into predominant IL-10 production via TLR2-dependent ERK activation in macrophages, J. Immunol., 184, 3505, 10.4049/jimmunol.0901569 · DOI · Paper page
- Kojouharoff, 1997, Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice, Clin. Exp. Immunol., 107, 353, 10.1111/j.1365-2249.1997.291-ce1184.x · DOI · Paper page
- Koninkx, 2010, Probiotic bacteria induced improvement of the mucosal integrity of enterocyte-like Caco-2 cells after exposure to Salmonella enteritidis 857, Funct. Foods, 2, 225, 10.1016/j.jff.2010.06.001 · DOI
- Li, 2003, Glutamine supports recovery from loss of transepithelial resitance and increase of permeability induced by media change in Caco-2 cells, J. Nutr. Biochem., 14, 401, 10.1016/S0955-2863(03)00071-8 · DOI
- Madsen, 2001, Probiotic bacteria enhance murine and human intestinal epithelial barrier function, Gastroenterology, 121, 580, 10.1053/gast.2001.27224 · DOI · Paper page
- Madsen, 1999, Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice, Gastroenterology, 116, 1107, 10.1016/S0016-5085(99)70013-2 · DOI · Paper page
- Marchiando, 2010, Epithelial barriers in homeostasis and disease, Annu. Rev. Pathol., 5, 119, 10.1146/annurev.pathol.4.110807.092135 · DOI · Paper page
- Meng, 2004, Antagonistic antibody prevent toll-like receptor 2-driven lethal shock-like syndromes, J. Clin. Invest., 113, 1473, 10.1172/JCI20762 · doi:10.1172/jci20762 · Paper page
- Mileti, 2009, Comparison of the immunomodulatory properties of three probiotic strains of lactobacilli using complex culture systems: Prediction for in vivo efficacy, PLoS ONE, 4, e7056, 10.1371/journal.pone.0007056 · DOI · Paper page
- Miyauchi, 2009, Lactobacillus rhamnosus alleviates intestinal barrier dysfunction in part by increasing expression of zonula occludens-1 and myosin light-chain kinase in vivo, J. Dairy Sci., 92, 2400, 10.3168/jds.2008-1698 · DOI · Paper page
- Nanda Kumar, 2008, Probiotic administration alters the gut flora and attenuates colitis in mice administered dextran sodium sulfate, J. Gastroenterol. Hepatol., 23, 1834, 10.1111/j.1440-1746.2008.05723.x · DOI · Paper page
- Neish, 2004, Molecular aspects of intestinal epithelial cell-bacterial interactions that determine the development of intestinal inflammation, Inflamm. Bowel Dis., 10, 159, 10.1097/00054725-200403000-00015 · DOI
- Obermeier, 1999, Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice, Clin. Exp. Immunol., 116, 238, 10.1046/j.1365-2249.1999.00878.x · DOI · Paper page
- Pronio, 2008, Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells, Inflamm. Bowel Dis., 14, 662, 10.1002/ibd.20369 · DOI · Paper page
- Rakoff-Nahoum, 2004, Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis, Cell, 118, 229, 10.1016/j.cell.2004.07.002 · DOI · Paper page
- Reiff, 2009, Balancing inflammatory, lipid and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowe disease, Inflamm. Bowel Dis., 15, 1721, 10.1002/ibd.20999 · DOI · Paper page
- Reiff, 2010, Inflammatory bowel disease, gut bacteria and probiotic therapy, Int. J. Med. Microbiol., 300, 25, 10.1016/j.ijmm.2009.08.004 · DOI · Paper page
- Resta-Lenert, 2006, Probiotics and commensals reverse TNF-α- and IFN-γ-induced dysfunction in human intestinal epithelial cells, Gastroenterology, 130, 731, 10.1053/j.gastro.2005.12.015 · DOI · Paper page
- Schlee, 2008, Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2, Clin. Exp. Immunol., 151, 528, 10.1111/j.1365-2249.2007.03587.x · DOI · Paper page
- Sherman, 2005, Probiotics reduce enterohemorrhagic Escherichia coli O157:H7 and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements, Infect. Immun., 73, 5183, 10.1128/IAI.73.8.5183-5188.2005 · DOI · Paper page
- Strober, 2002, The immunology of mucosal models of inflammation, Annu. Rev. Immunol., 20, 495, 10.1146/annurev.immunol.20.100301.064816 · DOI · Paper page
- Struyf, 2005, Chemokines synergize in the recruitment of circulating neutrophils into inflamed tissue, Eur. J. Immunol., 32, 1583, 10.1002/eji.200425753 · DOI
- Ulisse, 2001, Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: Effects of probiotic treatment, Am. J. Gastroenterol., 96, 2691, 10.1111/j.1572-0241.2001.04139.x · doi:10.1111/j.1572-0241.2001.04139.x · Paper page
- Vanderpool, 2008, Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel disease, Inflamm. Bowel Dis., 14, 1585, 10.1002/ibd.20525 · DOI · Paper page
- Voltan, 2008, Lactobacillus crispatus M247-derived H2O2 acts as a signal transducing molecule activating peroxisome proliferator activated receptor-γ in the intestinal mucosa, Gastroenterology, 135, 1216, 10.1053/j.gastro.2008.07.007 · DOI
- Vongsa, 2009, CCR6 regulation of the actin cytoskeleton orchestrates human beta defensin-2- and CCL20-mediated restitution of colonic epithelial cells, J. Biol. Chem., 284, 10034, 10.1074/jbc.M805289200 · DOI
- Zyrek, 2007, Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCζ redistribution resulting in tight junction and epithelial barrier repair, Cell. Microbiol., 9, 804, 10.1111/j.1462-5822.2006.00836.x · DOI · Paper page
Cited by
Milk kefir : nutritional, microbiological and health benefits
Rosa, D. D., Dias, M. M. S., Grześkowiak, Ł. M., Reis, S. A., Conceição, L. L., & Peluzio, M. D. C. G. (2017) · Nutrition Research Reviews · doi:10.1017/s0954422416000275 · Cited by 463
The Microbiota and Health Promoting Characteristics of the Fermented Beverage Kefir
Bourrie, B. C. T., Willing, B. P., & Cotter, P. D. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00647 · Cited by 438
Milk kefir: Composition, microbial cultures, biological activities, and related products
Prado, M. R., Blandón, L. M., Vandenberghe, L. P. S., Rodrigues, C., Castro, G. R., Thomaz-Soccol, V., & Soccol, C. R. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01177 · Cited by 423
Nutritional Keys for Intestinal Barrier Modulation
De Santis, S., Cavalcanti, E., Mastronardi, M., Jirillo, E., & Chieppa, M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00612 · Cited by 232
Kefir: A Multifaceted Fermented Dairy Product
Nielsen, B., Gürakan, G. C., & Ünlü, G. (2014) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-014-9168-0 · Cited by 140
Metadata
- Authors
- Chen, Y. P., Hsiao, P. J., Hong, W. S., Dai, T. Y., & Chen, M. J.
- Venue
- Journal of Dairy Science
- Publisher
- American Dairy Science Association
- Published
- 2012-01
- Volume
- 95
- Issue
- 1
- Pages
- 63-74
- ISSN
- 0022-0302 (ISSN-L)
- OpenAlex
- W2069214417
- Cited by
- 110
- References
- 12
- FWCI
- 7.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2572 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.